Patrick O'Donovan (Limerick, Fine Gael)
Link to this: Individually | In context

Question 377: To ask the Minister for Health if he will examine an issue (details supplied) regarding the national clinical programme on diabetes. [22911/12]

James Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context

The HSE Clinical Programmes Directorate are currently developing appropriate models of care to ensure the delivery of safe and effective services across diabetes outpatient services. This programme of work is ongoing and will inform the most appropriate structure, staffing and organisation of services.

As this is a service matter it has been referred to the HSE for direct reply.

Billy Kelleher (Cork North Central, Fianna Fail)
Link to this: Individually | In context

Question 378: To ask the Minister for Health the position regarding the case raised recently in the media regarding the provision of the drug Yervoy; and if he will make a statement on the matter. [22928/12]

Róisín Shortall (Dublin North West, Labour)
Link to this: Individually | In context

The Health Service Executive announced on Thursday 3rd of May that Ipilimumab (trade name Yervoy), the new drug for patients with progressive melanoma, will now be made available. The decision is the culmination of a comprehensive technology review process within the National Cancer Control Programme which included the drug company submission, a clinical practice guideline from medical oncologists and a pharmacoeconomic analysis by the National Centre for Pharmacoeconomics.